The role of autophagy in therapy-induced tumor cell death will be analyzed using pharmacological inhibitors of autophagy or by blocking the expression of genes required for autophagosome formation. The relationship between autophagy and different types of cell death (apoptosis, necrosis), as well as molecular mechanisms responsible for autophagy-mediated regulation of cancer cell death (modulation of mitochondrial membrane potential, oxidative stress, signaling pathways and expression of genes that regulate cell cycle and death) will also be analyzed. Therapeutic potential of pharmacological modulation of autophagy will be investigated in vivo using experimental models of cancer or by analyzing autophagy induction in clinical samples of tumor tissue and its correlation with clinical and molecular prognostic markers.
Dr. Ljubica Harharji-Trajković, project leader
Dr. Gordana Tovilović Kovačević
School of Medicine, University of Belgrade:
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.
IBISS uses analytical cookies to analyze the use of the site in order to improve the user experience, by clicking "Accept" you consent to the use of cookies.